Fitterfly HealthTech Pvt Ltd Logo
< Back to Listing
Journal Journal
Jul 2022 | Original research article | By Shefali Bhardwaj, Ruchira Ranadive, Sanjay Kalra, Archana Juneja, Kirti Samudra, Mahesh Padsalge, Piya Ballani, Sneha Kothari, Vishal Kini, Nikhil Chitnis, Ashish Sarawte, Sonali Patange, Dr Ritika Verma, Dr.Tejal Lathia , Dr. Snehal Tanna, Dr Arbinder Kumar Singal

Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days

Lifestyle management and behavioral modification is an integral aspect for the effective prevention and management of type 2 diabetes mellitus (T2D). Current study analysed the effectiveness of personalized glycemic response based Diabefly-Pro digital therapeutics program among 64 participants with T2D for better glycemic control. Out of all the participants, mean blood glucose, and time-above-range was significantly reduced by 17.5 mg/dL, 11% respectively, while the time in range significantly improved by 4.5%. Personalized glycemic response-based Diabefly-Pro digital therapeutics program was effective in achieving better glycemic control in people with T2D

Read full paper